Market Overview:
The global N-hydroxy-caprylohydroxamic acid market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for cosmetics additives and pharmaceutical intermediates. Additionally, the growing awareness about the benefits of N-hydroxy-caprylohydroxamic acid is also contributing to its growth. Some of the major players operating in this market are BASF SE (Germany), Akzo Nobel NV (Netherlands), and Evonik Industries AG (Germany).
Product Definition:
N-hydroxy-caprylohydroxamic acid is a derivative of caprylic acid that has been modified to include a hydroxyl group. This compound is used as an antibacterial agent and has been shown to be effective against a variety of pathogens, including MRSA.
Liquid:
Liquid is a key raw material used in the production of several pharmaceutical and nutraceutical products. It is also an intermediate used in the synthesis of caprolactam, which is widely employed across numerous end-use industries such as textile, automotive & transportation, construction materials and plastics. Increasing demand for liquid across these industries has led to high growth over the past few years owing to its properties such as low viscosity and high purity levels.
Powder:
Powder is a form of solid, which is used as an intermediate in manufacturing N-hydroxy-caprylohydroxamic acid. It can be prepared by the reaction of caprolactam with hydroxylamine. Caprolactam and hydroxylamine are reacted at elevated temperature to produce powder which is then used for the preparation of N-Hydroxy-caprylohydroxamic acid (HCA).
Application Insights:
The global N-hydroxy-caprylohydroxamic acid market has been segmented on the basis of application into cosmetics additives, pharmaceutical intermediates and other applications. The other applications include food additives and animal feed supplements. The demand for caprylate derivatives in these segments is expected to be driven by their use as preservatives in several industries including cosmetics, food and beverages.
Caprylate derivatives are used as excipients in drug delivery systems such as solid dosage forms (pills), tablets, patches (transdermal) and liquids that are used for the treatment of several chronic diseases such as cancer, diabetes mellitus type 2 etc. These drugs have a significant potential to replace conventional therapeutics owing to their anti-inflammatory & antifungal activities along with various other health benefits which makes them an attractive option among consumers worldwide. This factor is anticipated to drive product demand from pharmaceutical intermediates over the forecast period thereby contributing toward overall industry growth during this period.
Regional Analysis:
Asia Pacific dominated the global market in terms of revenue with a share of over 40.0% in 2017. The region is expected to witness significant growth due to increasing demand for pharmaceuticals and cosmetics products coupled with rising disposable income levels among consumers.
The presence of key manufacturers such as Shandong Tianzhan Chemical Co., Ltd.; SINOPEC; Sinomax Petrochemical Corporation; and CITIC Group has led to high demand for caprylohydroxamic acid from these industries, thereby boosting the regional market growth significantly. China is anticipated to be one of the major markets owing to its large population along with growing domestic production capabilities by companies such as Zhejiang Hengfeng Pharmaceutical (Group) Co., Ltd.; J&K Scientific LLC; and Jiangsu Luyuan Bio-Tech Co., Ltd.
Growth Factors:
- Increasing demand for green and environment-friendly products
- Rising awareness about the benefits of N-hydroxy-caprylohydroxamic acid
- Growing application areas of N-hydroxy-caprylohydroxamic acid
- Technological advancements in the production process of N-hydroxy-caprylohydroxamic acid
- Rising investments by key players in research and development to enhance product offerings
Scope Of The Report
Report Attributes
Report Details
Report Title
N-hydroxy-caprylohydroxamic acid Market Research Report
By Type
Liquid, Powder
By Application
Cosmetics additives, Pharmaceutical intermediates, Other
By Companies
Inolex, Simagchem Corporation, Hangzhou Lingeba Technology, TCI, Wuhan 3B Scientific Corporation, HBCChem, Beijing Yunbang Biosciences, BePharm Ltd, Yolne reagent, Aladdin, Inolex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global N-hydroxy-caprylohydroxamic acid Market Report Segments:
The global N-hydroxy-caprylohydroxamic acid market is segmented on the basis of:
Types
Liquid, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cosmetics additives, Pharmaceutical intermediates, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Inolex
- Simagchem Corporation
- Hangzhou Lingeba Technology
- TCI
- Wuhan 3B Scientific Corporation
- HBCChem
- Beijing Yunbang Biosciences
- BePharm Ltd
- Yolne reagent
- Aladdin
- Inolex
Highlights of The N-hydroxy-caprylohydroxamic acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid
- Powder
- By Application:
- Cosmetics additives
- Pharmaceutical intermediates
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the N-hydroxy-caprylohydroxamic acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
N-hydroxy-caprylohydroxamic acid is a molecule found in the body that helps to break down proteins.
Some of the key players operating in the n-hydroxy-caprylohydroxamic acid market are Inolex, Simagchem Corporation, Hangzhou Lingeba Technology, TCI, Wuhan 3B Scientific Corporation, HBCChem, Beijing Yunbang Biosciences, BePharm Ltd, Yolne reagent, Aladdin, Inolex.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 N-hydroxy-caprylohydroxamic acid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 N-hydroxy-caprylohydroxamic acid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 N-hydroxy-caprylohydroxamic acid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the N-hydroxy-caprylohydroxamic acid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global N-hydroxy-caprylohydroxamic acid Market Size & Forecast, 2020-2028
4.5.1 N-hydroxy-caprylohydroxamic acid Market Size and Y-o-Y Growth
4.5.2 N-hydroxy-caprylohydroxamic acid Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Liquid
5.2.2 Powder
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cosmetics additives
6.2.2 Pharmaceutical intermediates
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global N-hydroxy-caprylohydroxamic acid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 N-hydroxy-caprylohydroxamic acid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Liquid
9.6.2 Powder
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cosmetics additives
9.10.2 Pharmaceutical intermediates
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Liquid
10.6.2 Powder
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cosmetics additives
10.10.2 Pharmaceutical intermediates
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Liquid
11.6.2 Powder
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cosmetics additives
11.10.2 Pharmaceutical intermediates
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Liquid
12.6.2 Powder
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cosmetics additives
12.10.2 Pharmaceutical intermediates
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Liquid
13.6.2 Powder
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cosmetics additives
13.10.2 Pharmaceutical intermediates
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 N-hydroxy-caprylohydroxamic acid Market: Competitive Dashboard
14.2 Global N-hydroxy-caprylohydroxamic acid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Inolex
14.3.2 Simagchem Corporation
14.3.3 Hangzhou Lingeba Technology
14.3.4 TCI
14.3.5 Wuhan 3B Scientific Corporation
14.3.6 HBCChem
14.3.7 Beijing Yunbang Biosciences
14.3.8 BePharm Ltd
14.3.9 Yolne reagent
14.3.10 Aladdin
14.3.11 Inolex
